Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc. , a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for ...
SCHD is no longer an attractive long-term allocation, given recent reconstitution and macro dynamics favoring growth assets. Read more on SCHD ETF here.
Leaders of Hanoi, Ho Chi Minh City and Dong Nai shared experiences after one year of operating Vietnam s restructured ...
A Hanoi official called for further decentralisation to commune-level authorities in line with resource allocation, continued ...
We're grading the biggest NBA trades of the offseason, including the deal that sent big man Walker Kessler to the Lakers.
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
Michelle is a lead editor at Forbes Advisor. She has been a journalist for over 35 years, writing about insurance for consumers for the last decade. Prior to covering insurance, Michelle was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results